DJIA 17,813.39 1.20 0.01%
NASDAQ 5,116.14 0.00 0.00%
S&P 500 2,088.87 -0.27 -0.01%
market minute promo

Geron Corp (NASDAQ: GERN)

4.52 0.23 (5.36%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GERN $4.52 5.36%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.30
Previous Close $4.29
Daily Range $4.25 - $4.55
52-Week Range $2.60 - $4.67
Market Cap $715.2M
P/E Ratio 0.00
Dividend (Yield) $0.00 (0.0%)
Volume 2,723,804
Average Daily Volume 2,165,920
Current FY EPS -$0.05




Drug Makers

Geron Corp (GERN) Description

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS. Website:

News & Commentary Rss Feed

Time Provides the Best Cure for Geron's Recent Weakness

Calmer heads surrounding prescription drug reform and a corporate presentation set the stage for a huge gain in October.

Trade-Ideas: Geron (GERN) Is Today's Strong On High Relative Volume Stock

Geron Beats on Q3 Earnings & Revenues, Imetelstat in Focus

Geron's (GERN) CEO John Scarlett on Q3 2015 Results - Earnings Call Transcript

Will Geron (GERN) Post a Wider-than-Expected Loss in Q3?

Can the Rally in Geron (GERN) Shares Continue?

Top 2 Trade Alert Ideas October 14: Portola Milestone, Edge Granted ODD, Beaten Down Stocks

Unknown Small-Cap Stocks That Should Be on Your Radar

Wall Street is largely ignoring these small-cap stocks, but they have the potential to turn into absolute gems.

Should Geron Corporation (GERN) Be On Your Radar Now?

Can Geron (GERN) Run Higher on Strong Earnings Estimate Revisions?

See More GERN News...

GERN's Top Competitors

GERN $4.52 (5.36%)
Current stock: GERN
AMGN $163.95 (0.72%)
Current stock: AMGN
GILD $107.78 (1.14%)
Current stock: GILD
BIIB $292.30 (1.09%)
Current stock: BIIB